SCHEMBL13636765

SCHEMBL13636765

C(=C/c1ccc(C23CC4CC(CC(C4)C2)C3)cc1)\c1ccc(N(c2ccc(/C=C/c3ccc(C45CC6CC(CC(C6)C4)C5)cc3)cc2)c2ccc(/C=C/c3ccc(C45CC6CC(CC(C6)C4)C5)cc3)cc2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.50
ALDH1A1 P00352 3/20 0.50
GAA P10253 2/20 0.44
EPHX2 P34913 4/20 0.42
MEN1 O00255 3/20 0.42
KMT2A Q03164 3/20 0.42
POLB P06746 1/20 0.42
GFER P55789 1/20 0.42
NPC1 O15118 1/20 0.41
RARB P10826 2/20 0.40
RARA P10276 1/20 0.40
RARG P13631 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
MAPT P10636 2/20 0.39
RAB9A P51151 1/20 0.38
GRIN2D O15399 1/20 0.37
GRIN3B O60391 1/20 0.37
GRIN1 Q05586 1/20 0.37
GRIN2A Q12879 1/20 0.37
GRIN2B Q13224 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15468976 0.89 LMNA (0.61) LMNAALDH1A1GAAEPHX2MEN1
SCHEMBL13636772 0.85 ALDH1A1 (0.33) LMNAALDH1A1GAARARBRARA
SCHEMBL19089853 0.83 LMNA (0.44) LMNAALDH1A1GAAEPHX2MEN1
SCHEMBL23691300 0.82 LMNA (0.53) LMNAALDH1A1GAAEPHX2MEN1
SCHEMBL13721031 0.82 LMNA (0.53) LMNAALDH1A1GAAEPHX2MEN1
SCHEMBL13720720 0.82 LMNA (0.53) LMNAALDH1A1GAAEPHX2MEN1
SCHEMBL28060058 0.79 LMNA (0.50) LMNAALDH1A1GAAEPHX2MEN1
SCHEMBL28803691 0.79 LMNA (0.50) LMNAALDH1A1GAAEPHX2MEN1
SCHEMBL19089864 0.78 ALDH1A1 (0.40) LMNAALDH1A1GAAEPHX2MEN1
SCHEMBL23691172 0.78 LMNA (0.49) LMNAALDH1A1GAAEPHX2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8785001-B2 Organic electroluminescent devices MERCK PATENT GMBH (DE) 2014-07-22 US disclosed
US-8785001-B2 Organic electroluminescent devices MERCK PATENT GMBH (DE) 2014-07-22 US disclosed
US-8304095-B2 Organic electroluminescent devices MERCK PATENT GMBH (DE) 2012-11-06 US disclosed
US-20080297037-A1 Organic Electroluminescent Devices MERCK PATENT GMBH (DE) 2008-12-04 US disclosed
US-20080272693-A1 Organic Electroluminescent Devices MERCK PATENT GMBH (DE) 2008-11-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080272693-A1 Organic Electroluminescent Devices EML4, MT-ND4L, EPCAM LMNA 3117/4885ALDH1A1 600/4885GAA 2632/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.